Idorsia | Welcome to Idorsia Nordics

Idorsia Nordics was established to ensure that patients can benefit from the company’s pioneering therapies.

Idorsia's development compounds target a number of different diseases.

Find out how our team's passion for science will translate our objectives into value creation for all stakeholders.

Idorsia Pharmaceuticals Nordics AB

Gustav III:s Boulevard 42

c/o FirstOffice

169 73 Solna, Sweden

For more information and news about Idorsia Pharmaceuticals Ltd please visit our global corporate website.

The Idorsia site you have requested is intended for the residents of a particular country or countries. As a result, the site may contain information on pharmaceuticals and the use of these products that are not approved in the Nordic countries. Please use the decline button on your browser to return to the Idorsia Nordics website designed for residents of the Nordic countries, or please click proceed.